{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:30:38Z","timestamp":1793863838275,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023MH355"],"award-info":[{"award-number":["ZR2023MH355"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["2023CCG03"],"award-info":[{"award-number":["2023CCG03"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA0914300"],"award-info":[{"award-number":["2023YFA0914300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA0914302"],"award-info":[{"award-number":["2023YFA0914302"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373776"],"award-info":[{"award-number":["82373776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Polymers"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.carbpol.2025.123433","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T06:51:12Z","timestamp":1740207072000},"page":"123433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Rationally designed chemoenzymatic synthesis of heparan sulfate oligosaccharides with neutralizable anticoagulant activity and low severe complications"],"prefix":"10.1016","volume":"357","author":[{"given":"Guijiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"535","key":"10.1016\/j.carbpol.2025.123433_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav8075","article-title":"Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure","volume":"12","author":"Arnold","year":"2020","journal-title":"Science Translational Medicine"},{"issue":"12","key":"10.1016\/j.carbpol.2025.123433_bb0010","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.drudis.2020.09.011","article-title":"Advances in the preparation and synthesis of heparin and related products","volume":"25","author":"Baytas","year":"2020","journal-title":"Drug Discovery Today"},{"issue":"48","key":"10.1016\/j.carbpol.2025.123433_bb0015","doi-asserted-by":"crossref","first-page":"18724","DOI":"10.1073\/pnas.0806975105","article-title":"Redirecting the substrate specificity of heparan sulfate 2-O-sulfotransferase by structurally guided mutagenesis","volume":"105","author":"Bethea","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.carbpol.2025.123433_bb0020","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nature Communications"},{"issue":"8","key":"10.1016\/j.carbpol.2025.123433_bb0025","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1021\/acs.bioconjchem.2c00316","article-title":"When will Fondaparinux induce thrombocytopenia?","volume":"33","author":"Chen","year":"2022","journal-title":"Bioconjugate Chemistry"},{"issue":"26","key":"10.1016\/j.carbpol.2025.123433_bb0030","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1021\/jacs.9b03266","article-title":"An efficient modular one-pot synthesis of heparin-based anticoagulant Idraparinux","volume":"141","author":"Dey","year":"2019","journal-title":"Journal of the American Chemical Society"},{"issue":"2","key":"10.1016\/j.carbpol.2025.123433_bb0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/pharmrev.122.000684","article-title":"Pharmacology of heparin and related drugs: An update","volume":"75","author":"Hogwood","year":"2023","journal-title":"Pharmacological Reviews"},{"issue":"8","key":"10.1016\/j.carbpol.2025.123433_bb0040","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/glycob\/cwu032","article-title":"Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides","volume":"24","author":"Hsieh","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.carbpol.2025.123433_bb0045","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.carbpol.2017.05.071","article-title":"Probing cleavage promiscuity of heparinase III towards chemoenzymatically synthetic heparan sulfate oligosaccharides","volume":"173","author":"Hu","year":"2017","journal-title":"Carbohydrate Polymers"},{"issue":"11","key":"10.1016\/j.carbpol.2025.123433_bb0050","first-page":"36","article-title":"Diversifying the global heparin supply chain: Reintroduction of bovine heparin in the United States?","volume":"28","author":"Keire","year":"2015","journal-title":"Biopharm International"},{"key":"10.1016\/j.carbpol.2025.123433_bb0055","doi-asserted-by":"crossref","unstructured":"Kouta, A., Jeske, W., Cera, L., Farshid, A., Duff, R., Hoppensteadt, D., & Fareed, J. (2021). Protamine sulfate neutralization profile of various dosages of bovine, ovine and porcine UFHs and their depolymerized derivatives in non-human Primates. Clin Appl Thromb Hemost, 27.","DOI":"10.1177\/10760296211005544"},{"issue":"10","key":"10.1016\/j.carbpol.2025.123433_bb0060","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acschembio.1c00474","article-title":"Synthesis of 3-O-sulfated Heparan sulfate oligosaccharides using 3-O-sulfotransferase isoform 4","volume":"16","author":"Li","year":"2021","journal-title":"ACS Chemical Biology"},{"issue":"4","key":"10.1016\/j.carbpol.2025.123433_bb0065","article-title":"Using heparan sulfate octadecasaccharide (18-mer) as a multi-target agent to protect against sepsis","volume":"120","author":"Liao","year":"2023","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/j.carbpol.2025.123433_bb0070","article-title":"Milestone 1: Discovery and purification of heparin","volume":"14","author":"Lim","year":"2017","journal-title":"Nature Reviews. Cardiology"},{"issue":"2 Suppl","key":"10.1016\/j.carbpol.2025.123433_bb0075","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.carbpol.2025.123433_bb0080","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1074\/jbc.M113.530535","article-title":"Molecular mechanism of substrate specificity for heparan sulfate 2-O-sulfotransferase","volume":"289","author":"Liu","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.carbpol.2025.123433_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1039\/b819896a","article-title":"Lessons learned from the contamination of heparin","volume":"26","author":"Liu","year":"2009","journal-title":"Natural Product Reports"},{"issue":"36","key":"10.1016\/j.carbpol.2025.123433_bb0090","doi-asserted-by":"crossref","first-page":"33456","DOI":"10.1074\/jbc.M202034200","article-title":"Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D","volume":"277","author":"Liu","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"issue":"47","key":"10.1016\/j.carbpol.2025.123433_bb0095","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1021\/acs.orglett.3c03484","article-title":"Synthesis of anticoagulant Pentasaccharide Fondaparinux via 3,5-Dimethyl-4-(2\u2032-phenylethynylphenyl)phenyl glycosides","volume":"25","author":"Liu","year":"2023","journal-title":"Organic Letters"},{"issue":"19","key":"10.1016\/j.carbpol.2025.123433_bb0100","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1002\/anie.201800387","article-title":"Controlled Chemoenzymatic synthesis of Heparan sulfate oligosaccharides","volume":"57","author":"Lu","year":"2018","journal-title":"Angewandte Chemie (International Ed. in English)"},{"issue":"8","key":"10.1016\/j.carbpol.2025.123433_bb0105","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.carbpol.2025.123433_bb0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jth.14657","article-title":"Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins","volume":"18","author":"Nguyen","year":"2020","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.carbpol.2025.123433_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111561","article-title":"Pharmacological and clinical application of heparin progress: An essential drug for modern medicine","volume":"139","author":"Qiu","year":"2021","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.carbpol.2025.123433_bb0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1039\/b100916h","article-title":"Heparin and heparan sulfate: Structure and function","volume":"19","author":"Rabenstein","year":"2002","journal-title":"Natural Product Reports"},{"issue":"21","key":"10.1016\/j.carbpol.2025.123433_bb0125","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.jacc.2016.02.073","article-title":"Heparin-induced thrombocytopenia: A comprehensive clinical review","volume":"67","author":"Salter","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10.1016\/j.carbpol.2025.123433_bb0130","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1002\/anie.201609541","article-title":"A Hexasaccharide containing rare 2-O-sulfate-glucuronic acid residues selectively activates heparin cofactor II","volume":"56","author":"Sankarayanarayanan","year":"2017","journal-title":"Angewandte Chemie (International Ed. in English)"},{"issue":"12","key":"10.1016\/j.carbpol.2025.123433_bb0135","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1016\/j.jtha.2023.08.020","article-title":"New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry","volume":"21","author":"Shi","year":"2023","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.carbpol.2025.123433_bb0140","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1073\/pnas.252643299","article-title":"Rational design of low-molecular weight heparins with improved in vivo activity","volume":"100","author":"Sundaram","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.carbpol.2025.123433_bb0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nbt.3606","article-title":"The US regulatory and pharmacopeia response to the global heparin contamination crisis","volume":"34","author":"Szajek","year":"2016","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.carbpol.2025.123433_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119818","article-title":"Heparin: An old drug for new clinical applications","volume":"295","author":"Wang","year":"2022","journal-title":"Carbohydrate Polymers"},{"issue":"4","key":"10.1016\/j.carbpol.2025.123433_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nchembio.1459","article-title":"Homogeneous low-molecular-weight heparins with reversible anticoagulant activity","volume":"10","author":"Xu","year":"2014","journal-title":"Nature Chemical Biology"},{"issue":"406","key":"10.1016\/j.carbpol.2025.123433_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5954","article-title":"Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins","volume":"9","author":"Xu","year":"2017","journal-title":"Science Translational Medicine"},{"issue":"6055","key":"10.1016\/j.carbpol.2025.123433_bb0165","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.1207478","article-title":"Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins","volume":"334","author":"Xu","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.carbpol.2025.123433_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/acschembio.6b00841","article-title":"Structure based substrate specificity analysis of Heparan sulfate 6-O-sulfotransferases","volume":"12","author":"Xu","year":"2017","journal-title":"ACS Chemical Biology"},{"issue":"12","key":"10.1016\/j.carbpol.2025.123433_bb0175","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1021\/jacsau.2c00537","article-title":"Design and synthesis of Neutralizable Fondaparinux","volume":"2","author":"Zhang","year":"2022","journal-title":"JACS Au"}],"container-title":["Carbohydrate Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861725002140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861725002140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:30:33Z","timestamp":1762245033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0144861725002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":35,"alternative-id":["S0144861725002140"],"URL":"https:\/\/doi.org\/10.1016\/j.carbpol.2025.123433","relation":{},"ISSN":["0144-8617"],"issn-type":[{"value":"0144-8617","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationally designed chemoenzymatic synthesis of heparan sulfate oligosaccharides with neutralizable anticoagulant activity and low severe complications","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Polymers","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carbpol.2025.123433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123433"}}